Skip to main content

Chronic Pelvic Pain

3
Pipeline Programs
5
Companies
6
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
1
0
0
1
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 5 programs with unclassified modality

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Cumberland Pharmaceuticals
1 program
1
IV IbuprofenPhase 4Small Molecule1 trial
Active Trials
NCT01514175Unknown50Est. Dec 2012
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
1
Fuke Qianjin capsulePhase 21 trial
Active Trials
NCT03251560Unknown240Est. Dec 2018
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
1
PsilocybinPhase 11 trial
Active Trials
NCT06988319Not Yet Recruiting15Est. Dec 2026
Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
My Pelvic Plan WebsiteN/A1 trial
My Pelvic Plan websiteN/A1 trial
Active Trials
NCT06352840Completed70Est. Apr 2025
NCT06540560Completed30Est. Sep 2025
Saluda Medical
Saluda MedicalAustralia - Macquarie Park
1 program
Saluda Evoke Smart SCS SystemN/A1 trial
Active Trials
NCT06413277Recruiting20Est. Jan 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Cumberland PharmaceuticalsIV Ibuprofen
UNION therapeuticsFuke Qianjin capsule
Oregon TherapeuticsPsilocybin
Human BioSciencesMy Pelvic Plan website
Human BioSciencesMy Pelvic Plan Website
Saluda MedicalSaluda Evoke Smart SCS System

Clinical Trials (6)

Total enrollment: 425 patients across 6 trials

NCT01514175Cumberland PharmaceuticalsIV Ibuprofen

A Pilot Study Comparing the Analgesic Efficacy of IV Ibuprofen and IV Ketorolac

Start: Jan 2012Est. completion: Dec 201250 patients
Phase 4Unknown
NCT03251560UNION therapeuticsFuke Qianjin capsule

The Clinical Effect of Fuke Qianjin Capsule on Chronic Pelvic Pain Caused by Pelvic Inflammation

Start: Dec 2016Est. completion: Dec 2018240 patients
Phase 2Unknown
NCT06988319Oregon TherapeuticsPsilocybin

Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study

Start: Jan 2026Est. completion: Dec 202615 patients
Phase 1Not Yet Recruiting
NCT06540560Human BioSciencesMy Pelvic Plan website

Exploring Patient Treatment Preferences for Chronic Pelvic Pain: A Mixed Methods Study

Start: Apr 2025Est. completion: Sep 202530 patients
N/ACompleted
NCT06352840Human BioSciencesMy Pelvic Plan Website

Novel Web-based, Self-directed Intervention for Chronic Pelvic Pain

Start: Jun 2024Est. completion: Apr 202570 patients
N/ACompleted
NCT06413277Saluda MedicalSaluda Evoke Smart SCS System

Targeting the Conus Medullaris With ECAP-Controlled Closed-Loop SCS for Treatment of Chronic Pelvic Pain: HOPE Trial

Start: Feb 2024Est. completion: Jan 202720 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 425 patients
5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.